E.coli Testing Market Surpass USD 2,527.73 Mn by 2027 Says, The Insight Partners

According to our new market research study titled "E. coli Testing Market -Global Analysis and Forecast - by Technology and End User," the global E. coli testing market is expected to reach US$ 2,527.73 million by 2027 from US$ 1,506.95 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The report highlights the trends prevalent in the global E. coli testing market, and the drivers and deterrents pertaining to its growth.

The growth of the market is attributed to the factors such as increasing E. coli testing needs, growing product innovations, and rising research activities. On the other hand, testing challenges is the major factor is likely to restraint the market growth during the forecast period.

Request for sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00007152/?utm_source=OpenPR&utm_medium=10144

A few of the prominent players operating in the E. coli testing market are Bio-Rad Laboratories, Inc; Pro-Lab Diagnostics, Inc.; Abbott (Alere Inc.); IDEXX Laboratories, Inc.; Meridian Bioscience, Inc.; BD; Thermo Fisher Scientific, Inc.; CPI International; Biomerieux Inc.; and Hologic, Inc.

The market players are focused on acquisitions of other industry players to sustain their position in the market. For instance, in March, 2019, Meridian acquired GenePOC's molecular diagnostics business portfolio, with a main objective to leverage the rapid, high-quality diagnostics testing solutions of GenePOC as well as to guide and support the diagnosis for facilitating targeted therapeutic decisions for infectious diseases.

The E. coli testing market, by technology, is segmented monoclonal antibodies, differential light scattering, molecular diagnostics, immunoassays, chromatography, flow cytometry, gel microdroplets, and diagnostic imaging. The monoclonal antibodies segment held the largest share of the market in 2019. Monoclonal antibodies are widely used to detect the strains of E. coli in water and clinical samples, and they can identify a single epitope within an antigen, which is an advantage over the polyclonal antibodies. Thus, it is expected to retain its dominance during the forecast period. However, the immunoassays segment is estimated to register the highest CAGR in the market during the forecast period.

The report segments the global E. coli testing market as follows:

Global E. coli Testing Market - By Technology

Monoclonal Antibodies
Differential Light Scattering
Molecular Diagnostics
Immunoassays
Chromatography
Flow Cytometry
Gel Microdroplets
Diagnostic Imaging
Global E. coli Testing Market - By End User

Commercial or Private Labs
Physician Offices
Hospitals
Public Health Labs
Academic Research Institutes

Global E. coli Testing Market - By Geography

North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Asia Pacific (APAC)
Japan
China
India
Australia
South Korea
Middle East and Africa (MEA)
South Africa
UAE
Saudi Arabia
South and Central America
Brazil
Argentina

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00007152/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.